🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
Fat/Fatty Acid Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Total Fat
0.5 Gram(s) (1% DV)
Evening Primrose Oil
500 mg

Other Ingredients

Gelatin Glycerin Water

Label Claims — Verification

Nutrient
All Other
Structure/Function

Target Groups

Adult Female (18 - 50 Years) Dairy Free

Product Information

📋 Directions for Use

Directions: Take 1 softgel, two times daily, with a meal.

⚠️ Warnings & Precautions

Consult your healthcare professional prior to use if you have or suspect a medical condition, are taking prescription drugs, or are pregnant or lactating.

Keep out of reach of children.

🧪 Formulation Notes

Natrol Evening Primrose Oil is a natural source of gamma linolenic acid (GLA), and Omega-6 essential fatty acid necessary for normal body function.

Cold-pressed to provide greater health benefits than conventional evening primrose oil, it is traditionally used to support women's health.

Evening Primrose Oil 1000 mg per daily serving

Traditionally used to support women's health

No milk, egg, fish, crustacean shellfish, tree nuts, wheat, peanuts, soybeans, yeast, corn, artificial colors or flavors, added sugar, starch or preservatives

Additional Information

Store in a cool, dry place.

ITEM: 261 F: 3000013 L: 2004345-15163

Natural source of GLA

Product Details

UPC / SKU 0 47469 00261 9
DSLD Entry Date 2017-08-22
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand Natrol
DSLD ID 77412
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.